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The alterations of integrin glycosylation play a crucial role in tumormetastasis. Our previous studies
indicated that caveolin-1 promoted the expression of the key a2,6-sialytransferase ST6Gal-I and
ﬁbronectin-mediated adhesion of mouse hepatocarcinoma cell. Herein, we investigated the role
of a2,6-sialylated a5-integrin in the adhesion of mouse hepatocarcinoma H22 cell. We demon-
strated that caveolin-1 up-regulated cell surface a2,6-linked sialic acid via stimulating ST6Gal-I tran-
scription. Cell surface a2,6-sialylation was required for integrin a5b1-dependent cell adhesion to
ﬁbronectin, and an increase in a2,6-linked sialic acid on a5-subunit facilitated ﬁbronectin-mediated
focal adhesion kinase phosphorylations, suggesting that a2,6-sialylated a5-subunit promoted inte-
grin a5b1-dependent cell adhesion.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction in hepatocellular carcinogenesis (HCC) [6–9]. There is accumulat-Extracellular matrix (ECM) is an important regulator of cell
behaviours and microenvironment and consists of many mole-
cules, such as ﬁbronectin (Fn), collagen (Col), laminin (Ln), proteo-
glycans and non-matrix proteins [1]. Enhanced tumor cell adhesion
to ECM is a key step to induce cell invasion in tumor metastasis [2].
Integrins are transmembrane glycoproteins that form non-covalent
heterodimers composed of a- and b-subunits. Members of integrin
family are the major cell surface receptor for ECM and play a cru-
cial role in mediating cell–ECM interactions during cell prolifera-
tion, development and tumor malignant behaviours [3].
Glycosylation, as a post-translational modiﬁcation reaction, is tis-
sue speciﬁc and developmentally regulated by the activity of glyco-
syltransferases and glycosidases. Although integrin-dependent cell
adhesion is based on the binding of integrin to deﬁned peptide se-
quence of ECM protein, this interaction is regulated by various fac-
tors including glycosylation modiﬁcation [4].
Caveolin-1 (Cav-1) is identiﬁed as a major structural protein of
caveolae and is implicated in lipid transport, signal transduction
and tumor progression [5]. Current studies demonstrated that
Cav-1 positively regulated tumor growth and metastatic abilitying evidence that Cav-1 may participate in the regulation of glyco-
sylation modiﬁcation. Cav-1 could mediate the subcompartmental
localization of glycosyltransferase N-acetylglucosaminyltransfer-
ase III in Huh6 cell [10]. a2,6-Linked sialic acid is catalyzed by b-
galactoside:a2-6-sialyltransferase 1 (ST6Gal-I), which adds sialic
acid attached to Galb1-4GlcNAc in a a2,6 linkage. Elevated levels
of ST6Gal-I and a2,6-linked sialic acid had been observed in carci-
nomas of cervix, brain and liver [11–13]. However, the regulation
mechanisms and roles of aberrant a2,6-sialylation in HCC progres-
sion are poorly understood.
H22 is a mouse hepatocarcinoma cell line with high metastasis
potential. Our present study found that knockdown of Cav-1 in
H22 cells down-regulated cell surface a2,6-linked sialic acid
through inhibiting ST6Gal-I transcription, which could be restored
by the reintroduction of wild-type Cav-1. Cell surface a2,6-sialyla-
tion-induced enhancement of cell adhesion to Fn was strongly sup-
pressed by function-blocking antibody against a5- or b1-subunit.
Furthermore, an increase in a2,6-linked sialic acid on a5-subunit
up-regulated the Fn-mediated focal adhesion kinase (FAK)
phosphorylations.
2. Materials and methods
2.1. Cell culture
Mouse hepatocarcinoma cell line H22 was obtained from Cell
Center of Peking Union Medical University (Beijing) and main-
tained in Rosewell Park Memorial Institute (RPMI) 1640 medium
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um (FBS) (Gibco) under a humidiﬁed atmosphere of 95% air and
5% CO2.
2.2. Construction of RNA interference vector and transfection
Three Cav-1-speciﬁc small hairpin RNA (shRNA) sequences used
in the construction of RNA interference (RNAi) vector were as fol-
lows, shRNA-1: 50-CACCGTACCTGAGTCTCCAGAAATTCAAGAGATTT
CTGGAGACTCAGGTACTTTTTTG-30 and 50-GATCCAAAAAAGTACCTG
AGTCTCCAGAAATCTCTT GAATTTCTGGAGACTCAGGTAC-30; shRNA-
2: 50-CACCGCCACTCAGCAACTGAATGA TTCAAGAGATCATTCAGTTG
CTGAGTGGTTTTTTG-30 and 50-GATCCAAAAAACCACTCAGCAA
CTGAATGATCTCTTGAATCATTCAGTTGCTGAGTGGC-30; shRNA-3:
50-CACCGTACCTGAGTCTCCAGAAATT CAAGAGATTTCTGGAGACTCA
GGTACTTTTTTG-30 and 50-GATCCAAAAAAGTACCTGAGTCTCCAGA
AATCTCTTGAATTTCTGGAGACTCAGGTAC-30. Three shRNAs were
annealed and ligated into pGPU6 vector (GenePharma) to generate
shRNA constructs (shCav-1-1, shCav-1-2 and shCav-1-3), respec-
tively. Negative control shRNA construct (shNC) was used as a con-
trol. H22 cells were transfected with the mixture of plasmids and
Lipofectamine™ 2000 (Invitrogen) according to manufacturer’s
recommendation.
2.3. Construction of rescue vector and transfection
Construction of expression vector encoding wild-type Cav-1 or
ST6Gal-I had been described previously [14]. Rescue vectors were
transfected into Cav-1 knockdown H22 cells, respectively. After
48 h transfection, Cav-1- and ST6Gal-I-rescued cells were used to
perform the following assays.
2.4. Construction of luciferase reporter vector, transfection and
promoter activity assay
The transcriptional start site for mouse ST6Gal-I gene was re-
trieved from UCSC Genome Browser (http://genome.ucsc.edu). A
2000-bp region upstream of the transcriptional start site was sub-
cloned into pGL3-basic vector (ﬁreﬂy luciferase reporter vector)
(Promega) to generate pGL3-basic/ST6Gal-I vector. The pGL3-ba-
sic/ST6Gal-I construct and control plasmid pRL-TK (Promega),
which expresses Renilla luciferase under the control of TK pro-
moter, were cotransfected into negative control, three Cav-1-
shRNA and wild-type Cav-1-rescued transfectants by using Lipo-
fectamine™ 2000 (Invitrogen), respectively. After 24 h transfec-
tion, ﬁreﬂy luciferase and Renilla luciferase activities were
measured using Dual-Luciferase Assay Kit (Promega) as described
by manufacturer. Fireﬂy luciferase activities were normalized
against the Renilla luciferase activities.
2.5. Real-time PCR analysis
Real-time PCR was performed as described previously [14]. Rel-
ative Cav-1 and ST6Gal-I mRNA levels were normalized with GAP-
DH and calculated using 2DDCT method.
2.6. Western blot analysis
Protein concentration was measured with BCA assay kit
(Pierce). Equal amounts of denatured proteins were subjected to
10% SDS–PAGE and blotted onto nitrocellulose membranes (Pall
Corporation). Antibodies against a5-subunit, b1-subunit, Cav-1,
ST6Gal-I, FAK, phosphorylated FAK (p-FAK), paxillin, p-paxillin,
ERK1/2, p-ERK1/2 and GAPDH (Santa Cruz Biotech Inc.) were used
as the primary antibodies. The detection was performed using ECL
kit (Amersham Biosciences) according to manufacturer’s instruc-tions. Relative amount of protein was determined by densitometry
using LabWorks software.
2.7. Lectin blot analysis
Cells were harvested, rinsed with PBS, and lysed with Proteo-
Prep Membrane Extraction Kit (Sigma–Aldrich). The lysates con-
taining equal amounts of denatured proteins were subjected to
8% SDS–PAGE and transferred to nitrocellulose membranes. The
identiﬁcation was performed with 2 lg/ml biotinylated Sambucus
nigra (SNA) lectin (Vector Laboratories, Inc.), which preferentially
recognizes sialic acid attached to terminal galactose in a a2,6-link-
age. The blots were developed using ECL detection system (Amer-
sham Biosciences).
2.8. Flow cytometry analysis
Cells were blocked with PBS containing 1% bovine serum albu-
min (BSA), and then incubated with 2 lg/ml FITC-conjugated SNA
lectin for 30 min on ice. For the analysis of a5- or b1-subunit, cells
were treated with the primary antibody against a5- or b1-subunit
for 1 h on ice, and then incubated with FITC-conjugated goat anti-
rabbit IgG for 1 h on ice. After washing thrice with PBS, cells were
analyzed using a FACScan instrument (BD Biosciences).
2.9. Immunoprecipitation and Western blot
Cells were lysed with ProteoPrep Membrane Extraction Kit
(Sigma–Aldrich). Protein concentration was measured with BCA
assay kit (Pierce). The lysates containing equal amounts of proteins
were incubated with 2 lg of anti-a5 subunit antibody and then
with 50 ll protein A-agarose beads (Invitrogen). Immunoprecipi-
tates were subjected to 8% SDS–PAGE and transferred to nitrocellu-
lose membranes. The blots were probed with biotinylated SNA
lectin and anti-a5 subunit antibody, respectively, and developed
using ECL detection system (Amersham Biosciences).
2.10. Cell adhesion assay
Cell adhesion assay was performed as described previously [14].
For adhesion inhibition assays, cells were pre-incubated with con-
trol IgG (5 lg/ml), EDTA (5 mM), function-blocking anti-a5 or anti-
b1 subunit antibody (2.5 lg/ml or 5 lg/ml) for 20 min at room
temperature before inoculation.
2.11. Statistical analysis
The data were expressed as the mean ± S.E. Statistical analysis
was performed with SPSS 13.0 software. One-way ANOVA with
post hoc Tukey’s test was performed for experiments that involved
more than two groups, and Student’s t-test was performed for
comparisons between two groups. P < 0.05 was considered to be
statistically signiﬁcant.3. Results
3.1. Knockdown of Cav-1 in H22 cells reduces cell surface a2,6-linked
sialic acid via down-regulating ST6Gal-I transcription
To investigate a possible relationship between Cav-1 and cell
surface a2,6-sialylation, we developed three shRNA interference
vectors (shCav-1-1, shCav-1-2 and shCav-1-3) to silence Cav-1
expression in H22 cells, respectively. Cav-1 and ST6Gal-I expres-
sion were suppressed in different Cav-1-shRNA transfected cells
(Fig. 1A and B), and shCav-1-1 transfectant exhibited a weaker
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shCav-1-2 or shCav-1-3 transfectant (Fig. 1C). Thus, shCav-1-1
was used to perform the following assays. SNA lectin staining
and ﬂow cytometry results showed that the levels of a2,6-linked
sialic acid on cell surface were notably decreased in shCav-1-1
transfectant compared with negative control transfectant (shNC)
(Fig. 1D and E). These results indicate that knockdown of Cav-1
down-regulates cell surface a2,6-sialylation through inhibiting
ST6Gal-I transcription.
3.2. Re-expression of Cav-1 in Cav-1-silenced H22 cells restores cell
surface a2,6-linked sialic acid
To further investigate the effect of Cav-1 on cell surface a2,6-
sialylation, wild-type Cav-1 or ST6Gal-I was transfected into Cav-
1 knockdown H22 cells. ST6Gal-I expression was remarkably up-
regulated in Cav-1- or ST6Gal-I-rescued cells as compared toFig. 1. Knockdown of Cav-1 in H22 cells reduces cell surface a2,6-linked sialic acid via
measured using real-time PCR with RNA extracted from three Cav-1-shRNA respectivel
transfected cells (shNC). (B) Western blot analysis of Cav-1 and ST6Gal-I protein levels in
(C) ST6Gal-I promoter activity assay in shCav-1-1, shCav-1-2, shCav-1-3 and shNC cel
luciferase levels. The plasmid pRL-TK was cotransfected in all experiments and used as i
levels were detected in the total membrane protein extracted from shCav-1-1 and shNC c
the comparable amounts of protein in each lane. (E) Flow cytometry analysis of shCav-1-1
were as a control. The error bar shows the S.E. for ﬁve independent experiments, and eachnon-rescued Cav-1 knockdown cells (Fig. 2A and B). Consistently,
the transfection of Cav-1 into Cav-1-silenced cells resulted in a
notable restoration of ST6Gal-I promoter controlled luciferase
activity (Fig. 2C). Cav-1- or ST6Gal-I-rescued cells showed a signif-
icant increase in the levels of cell surface a2,6-linked sialic acid
compared with non-rescued cells as revealed by SNA lectin stain-
ing and ﬂow cytometry analyses (Fig. 2D and E). These results
strongly suggest that down-regulation of cell surface a2,6-sialyla-
tion, induced by Cav-1 knockdown, can be resistant by the reintro-
duction of wild-type Cav-1 or ST6Gal-I.
3.3. Cell surface a2,6-linked sialic acid mediates integrin a5b1-
dependent cell adhesion to Fn
The effects of Cav-1 on H22 cell adhesion were examined, as
shown in Fig. 3A, the transfection of shCav-1-1 into H22 cells
greatly reduced the cell adhesion to Fn compared with negativedown-regulating ST6Gal-I transcription. (A) Cav-1 and ST6Gal-I mRNA levels were
y transfected H22 cells (shCav-1-1, shCav-1-2 and shCav-1-3) and negative control
shCav-1-1, shCav-1-2, shCav-1-3 and shNC cells. GAPDH blotting served as a control.
ls. Promoter activity is expressed as ﬁreﬂy luciferase value normalized for Renilla
nternal control to normalize the transfection efﬁciencies. (D) a2,6-linked sialic acid
ells using SNA lectin staining. Coomassie Brilliant Blue (CBB) staining of gels showed
and shNC cells with FITC-conjugated SNA lectin. shNC cells stained with FITC alone
experiment contains 3–5 independent samples. ⁄P < 0.01; ⁄⁄P < 0.005; ⁄⁄⁄P < 0.0001.
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in the adhesion of both cells to Col or Ln. We had veriﬁed that
Cav-1 could up-regulate a2,6-linked sialic acid on H22 cell surface
(see Fig. 2), and the further study was to observe the role of cell
surface a2,6-sialylation in cell adhesion to Fn. The re-expression
of wild-type ST6Gal-I in Cav-1 knockdown cells signiﬁcantly re-
stored the reduced adhesion of Cav-1-silenced cells (Fig. 3B). Inte-
grin a5b1 is a speciﬁc receptor for Fn. Furthermore, the divalent
cation is necessary for integrin–ligand binding [15]. The monoclo-
nal antibodies against a5- and b1-subunits and the divalent cation
chelator EDTA were used to detect Fn-mediated cell adhesion,
respectively. The adhesion of non-rescued Cav-1 knockdown cells
was more prone to be blocked as compared to that of ST6Gal-I-res-
cued cells in the presence of anti-a5 or anti-b1 subunit antibody,Fig. 2. Re-expression of Cav-1 in Cav-1-silenced H22 cells restores cell surface a2,6-link
with RNA extracted from shNC, shCav-1-1, Cav-1-rescued and ST6Gal-I-rescued Cav-1 k
shNC, shCav-1-1, Cav-1-rescued and ST6Gal-I-rescued cells. (C) ST6Gal-I promoter activit
were detected in the total membrane protein extracted from shNC, shCav-1-1, Cav-1-
analysis of shNC, shCav-1-1, Cav-1-rescued and ST6Gal-I-rescued cells with FITC-conjug
shows the S.E. for ﬁve independent experiments, and each experiment contains 3–5 indand EDTA inhibited the adhesion of both cells to Fn (Fig. 3C). These
results suggest that cell surface a2,6-linked sialic acid is required
for the binding of integrin a5b1 and Fn.
3.4. The increase in a2,6-sialylation on a5-subunit up-regulates FAK
signaling
Glycosylation modiﬁcation contributes to the binding of inte-
grins and ECM proteins [4]. Herein, the a5-subunit was immuno-
precipitated from the total membrane protein of Cav-1-rescued,
ST6Gal-I-rescued, shCav-1-1 or control transfectant, and then
probed with SNA lectin or anti-a5 subunit antibody. Fig. 4A (top)
showed that the transfection of shCav-1-1 into H22 cells resulted
in a decrease in the a2,6-linked sialic acid on a5-subunit, whiched sialic. (A) Cav-1 and ST6Gal-I mRNA levels were measured using real-time PCR
nockdown cells. (B) Western blot analysis of Cav-1 and ST6Gal-I protein levels in
y assay in shNC, shCav-1-1 and Cav-1-rescued cells. (D) a2,6-Linked sialic acid levels
rescued and ST6Gal-I-rescued cells using SNA lectin staining. (E) Flow cytometry
ated SNA lectin. shNC cells stained with FITC alone were as a control. The error bar
ependent samples. ⁄⁄⁄P < 0.0001.
Fig. 3. Cell surface a2,6-linked sialic acid mediates integrin a5b1-dependent cell
adhesion to Fn. (A) Cell adhesion assay of shNC and shCav-1-1 cells to Fn, Col or Ln
at different concentrations (5 nM or 10 nM). The adhesion of cells to BSA or PL was
used as negative or positive control. (B) Cell adhesion assay of shNC, shCav-1-1 and
ST6Gal-I-rescued cells to Fn. (C) The effects of a5- or b1-subunit function-blocking
on the adhesion of shCav-1-1 and ST6Gal-I-rescued cells to Fn. The cells were pre-
incubated with control IgG (5 lg/ml), EDTA (5 mM), function-blocking anti-a5 or
anti-b1 subunit antibody (2.5 lg/ml or 5 lg/ml), and allowed to adhere to Fn
(5 nM). The error bar shows the S.E. for ﬁve independent experiments, and each
experiment contains 3–5 independent samples. ⁄P < 0.01; ⁄⁄P < 0.005; ⁄⁄⁄P < 0.0001.
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shCav-1-1 transfectant. Equivalent amounts of the a5-subunit
were veriﬁed by blotting a5-immunoprecipitated lysates (Fig. 4AFig. 4. The increase in a2,6-sialylation on a5-subunit up-regulates FAK signaling. (A) The
shNC, shCav-1-1, Cav-1-rescued and ST6Gal-I-rescued cells. The whole membrane lysate
probed by SNA lectin (top) and anti-a5 subunit antibody (bottom) (WB, Western blot)
Western blot analysis of a5- and b1-subunits protein levels in shNC, shCav-1-1, Cav-1-re
levels on cell surface of shNC, shCav-1-1, Cav-1-rescued and ST6Gal-I-rescued cells. shN
analysis of phosphorylated FAK, paxillin and ERK1/2 levels in shNC, shCav-1-1, Cav-1-res
seeded into dishes coated with Fn (10 nM). The cell lysates were identiﬁed with either an
levels of FAK, paxillin and ERK1/2 or with anti-FAK, anti-paxillin and anti-ERK1/2 antibbottom). One possible explanation for the effect of integrin a5b1
on cell adhesion is the change in the expression of a5- or b1-sub-
unit [16]. As shown in Fig. 4B and C, Cav-1 and ST6Gal-I had no sig-
niﬁcant effect on the expression of cell surface a5- or b1-subunit.
The interaction of integrin and ECM can preferentially lead to
intracellular FAK and paxillin phosphorylations in response to
cell–matrix contact [17]. After the treatment with Fn, phosphory-
lated FAK and paxillin were notably down-regulated in shCav-1-1
transfectant compared with control transfectant and were remark-
ably recovered in Cav-1- or ST6Gal-I-rescued Cav-1 knockdown
cells (Fig. 4D). These results suggest that the increase in a2,6-
linked sialic acid on a5-subunit facilitates Fn-mediated FAK
phosphorylations.
4. Discussion
Aberrant protein glycosylation has been linked to various dis-
eases including cancer [18]. Current studies suggested that Cav-1
might play an important role in regulating gene expression and
protein glycosylation. Glait et al. demonstrated that Cav-1 could
stimulate BRCA1 gene transcription in human breast cancer cell
line MCF7 [19]. Sengupta et al. reported that Wnt/beta-catenin
signaling could induce the expression of glycosyltransferase
gene DPAGT1[20], and Cav-1 is necessary for the activation of
Wnt-3a-dependent Wnt/beta-catenin signaling pathway [21]. Our
previous studies showed that Cav-1 promoted tumor cell
migration and invasion through up-regulating N-glycan levels of
matrix metalloproteinase inducer CD147 [22].
In the present study, Cav-1 silencing down-regulated the levels
of a2,6-linked sialic acid on H22 cell surface, which could be re-
stored by the reintroduction of wild-type Cav-1. Consistently,
Cav-1 could drive the ST6Gal-I promoter controlled luciferase
activity. Our earlier study indicated that Cav-1 scaffolding domainanalysis of a2,6-linked sialic acid on a5-subunit from the total membrane protein of
s were immunoprecipitated (IP) with anti-a5 subunit antibody, and the blots were
, respectively. IgG immunoprecipitates from shNC cells were used as a control. (B)
scued and ST6Gal-I-rescued cells. (C) Flow cytometry analysis of a5- and b1-subunit
C cells stained only with FITC-conjugated IgG were as a control. (D) Western blot
cued and ST6Gal-I-rescued cells treated with Fn (10 nM). Serum-starved cells were
ti-p-FAK, anti-p-paxillin and anti-p-ERK1/2 antibodies to verify the phosphorylation
odies to detect total amount of FAK, paxillin and ERK1/2.
S. Yu et al. / FEBS Letters 587 (2013) 782–787 787(CSD) up-regulated ST6Gal-I expression in mouse hepatocarci-
noma cells [14]. CSD is located in the NH2-terminal region of
Cav-1 and can orchestrate various signaling molecules containing
a caveolin-binding domain, such as Rho-GTPases. Arpaia et al.
demonstrated that the interaction between CSD and Rho-GTPases
promoted Src-dependent activation of Ras signaling [23], and Ras
oncogene could stimulate ST6Gal-I expression [24]. We speculated
that Cav-1 might be indirectly involved in modulating ST6Gal-I
expression, and the detailed mechanisms deserve further study.
Although it is well established that Cav-1 acts as a tumor pro-
moter in some organs, including the liver [25–28], the molecule
mechanisms involved are poorly understood. Tumor-associated
alteration in cell–ECM interaction is the start factor for tumor cell
migration and invasion [2]. In this study, we provided the evidence
that knockdown of Cav-1 in H22 cells inhibited the adhesion of cell
to Fn. Dall’Olio et al. reported that ST6Gal-I expression and a2,6-
sialylated glycoconjugates in human HCC tissue were up-regulated
compared with in cirrhosis and normal liver tissue [13]. However,
the roles of increased a2,6-sialylation in liver cancer development
remain unknown.We had veriﬁed that Cav-1 could up-regulate the
levels of cell surface a2,6-linked sialic acid. The further study dem-
onstrated that a2,6-linked sialic acid on H22 cell surface directly
mediated the effect of Cav-1 on cell adhesion to Fn. Thus, Cav-1-
regulated a2,6-sialylation may be an important early event for
HCC metastasis.
Integrina5b1 is amajor receptor for Fn, and glycosylation of inte-
grin has been proposed to be involved in tumormigration and inva-
sion [29,30]. Isaji et al. found that the introduction of b1,4-N-
acetylglucosaminyltransferase III (GnT-III) in human cervical cancer
cell HeLa S3 increased the bisecting GlcNAc on a5-subunit of inte-
grin a5b1 and reduced the cell adhesion and migration [31]. In this
study, the adhesionof non-rescuedCav-1 knockdowncells to Fnwas
more prone to be inhibited compared with that of ST6Gal-I-rescued
cells by the antibody against a5- or b1-subunit. Furthermore, the
levels of a2,6-linked sialic acid on a5-subunit and Fn-mediated
FAK phosphorylation were reduced in Cav-1-silenced H22 cells
and were signiﬁcantly restored by the re-expression of Cav-1 or
ST6Gal-I. These results suggest that Cav-1 can up-regulate integrin
a2,6-sialylation, and a2,6-sialylated a5-subunit mediates integrin
a5b1-dependent cell adhesion and FAK signaling.
Taken together, we demonstrate for the ﬁrst time that Cav-1
can promote the a2,6-sialylation on cell surface. a2,6-Sialylated
a5-subunit plays a key role in modulating integrin a5b1-depen-
dent cell adhesion and FAK signaling pathway. This study provides
new insights into the biological functions of Cav-1 and the signiﬁ-
cance of sialylation modiﬁcation for a5b1 integrin in HCC
metastasis.
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